{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:43Z","timestamp":1793900503390,"version":"4.8.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory cytokines have been considered to be significant factors contributing to the development and progression of non-alcoholic fatty liver disease (NAFLD). However, the role of inflammatory cytokines in NAFLD remains inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the association between inflammatory cytokines and NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Web of Science, the Cochrane Library, and EMBASE databases were searched until 31 December 2021 to identify eligible studies that reported the association of inflammatory cytokine with NAFLD and its subtypes. We pooled odds ratios (ORs) and hazard risk (HRs) with 95% confidence intervals (CIs) and conducted heterogeneity tests. Sensitivity analysis and analysis for publication bias were also carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search in the databases identified 51 relevant studies that investigated the association between 19 different inflammatory cytokines and NAFLD based on 36,074 patients and 47,052 controls. The results of the meta-analysis showed significant associations for C-reactive protein (CRP), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (IL-6), tumor necrosis factor-\u03b1 (TNF-\u03b1), and intercellular adhesion molecule-1 (ICAM-1) with NAFLD (ORs of 1.41, 1.08, 1.50, 1.15 and 2.17, respectively). In contrast, we observed non-significant associations for interferon-\u03b3 (IFN-\u03b3), insulin-like growth factor (IGF-II), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-7 (IL-7), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-12 (IL-12), monocyte chemoattractant protein-1(MCP-1), and transforming growth factor-\u03b2 (TGF-\u03b2) with NAFLD. Our results also showed that CRP, IL-1\u03b2, and TNF-\u03b1 were significantly associated with non-alcoholic steatohepatitis (NASH) and hepatic fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicated that increased CRP, IL\u20101\u03b2, IL-6, TNF\u2010\u03b1, and ICAM-1 concentrations were significantly associated with increased risks of NAFLD. These inflammatory mediators may serve as biomarkers for NAFLD subjects and expect to provide new insights into the aetiology of NAFLD as well as early diagnosis and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.880298","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T02:18:14Z","timestamp":1651803494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":356,"title":["Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Yamei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince L.","family":"Bestman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-Alcoholic Fatty Liver Disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11892-019-1151-4","article-title":"Epigenetic Markers and Microbiota\/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease","volume":"19","author":"Stols-Gon\u00e7alves","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s40064-015-1542-1","article-title":"Global Publication Trends and Research Hotspots of Nonalcoholic Fatty Liver Disease: A Bibliometric Analysis and Systematic Review","volume":"4","author":"Zhang","year":"2015","journal-title":"SpringerPlus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.3390\/ijms21114189","article-title":"Relationship Between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women With Morbid Obesity and Nonalcoholic Steatohepatitis","volume":"21","author":"Auguet","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature10809","article-title":"Inflammasome-Mediated Dysbiosis Regulates Progression of NAFLD and Obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31658","article-title":"Myeloid-Cell-Specific IL-6 Signaling Promotes Microrna-223-Enriched Exosome Production to Attenuate Nafld-Associated Fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.07.002","article-title":"Laparoscopic Sleeve Gastrectomy Reverses non-Alcoholic Fatty Liver Disease Modulating Oxidative Stress and Inflammation","volume":"99","author":"Cabr\u00e9","year":"2019","journal-title":"Metabol: Clin Exp"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1601923","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic Fatty Liver Disease in Chronic Obstructive Pulmonary Disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur Respir J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular Pathways of Nonalcoholic Fatty Liver Disease Development and Progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate Immunity and Inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Digest Dis Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the Inflammasome in Liver Disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PloS Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111695.t001","article-title":"Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies","author":"Feng","year":"2014","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000486","article-title":"A Novel Model Using Mean Platelet Volume and Neutrophil to Lymphocyte Ratio as a Marker of Nonalcoholic Steatohepatitis in NAFLD Patients: Multicentric Study","volume":"28","author":"Abdel-Razik","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hep.28776","article-title":"Novel Plasma Biomarkers Associated With Liver Disease Severity in Adults With Nonalcoholic Fatty Liver Disease","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0022034517720924","article-title":"Do Genetic Markers of Inflammation Modify the Relationship Between Periodontitis and Nonalcoholic Fatty Liver Disease","volume":"96","author":"Akinkugbe","year":"2017","journal-title":"Findings SHIP Study J Dent Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children","volume":"50","author":"Alisi","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The Association of Nonalcoholic Fatty Liver Disease, Obesity, and Metabolic Syndrome, With Systemic Inflammation and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (Mesa)","volume":"239","author":"Al Rifai","year":"2015","journal-title":"Atherosclerosis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/nu12061650","article-title":"Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-Beta) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study","volume":"12","author":"Barretto","year":"2020","journal-title":"Nutrients"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5163","article-title":"LPS-Induced TNF-\u03b1 Factor Mediates Pro-Inflammatory and Pro-Fibrogenic Pattern in non-Alcoholic Fatty Liver Disease","volume":"6","author":"Ceccarelli","year":"2015","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e31799","DOI":"10.1371\/journal.pone.0031799","article-title":"Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients With Nonalcoholic Fatty Liver Disease","volume":"7","author":"Chiang","year":"2012","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.238","article-title":"The Relation Between non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans","volume":"104","author":"Choi","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.6336","article-title":"The Development of a Clinical Score for the Prediction of Nonalcoholic Steatohepatitis in Patients With Nonalcoholic Fatty Liver Disease Using Routine Parameters","volume":"26","author":"Chunming","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001354","article-title":"Serum Fetuin-B Level is an Independent Marker for Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes","volume":"31","author":"El-Ashmawy","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11695-007-9087-1","article-title":"IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and non-Alcoholic Steatohepatitis in Morbidly Obese Patients","volume":"17","author":"Garc\u00eda-Galiano","year":"2007","journal-title":"Obes Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20174","article-title":"Nonalcoholic Fatty Liver Disease in Severely Obese Adolescent and Adult Patients","volume":"21","author":"Holterman","year":"2013","journal-title":"Obes (Silver Spring)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13104-016-2071-x","article-title":"Subclinical Inflammation in Relation to Insulin Resistance in Prediabetic Subjects With Nonalcoholic Fatty Liver Disease","volume":"9","author":"Hossain","year":"2016","journal-title":"BMC Res Notes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond Insulin Resistance in NASH: TNF-Alpha or Adiponectin","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001393","article-title":"Neutrophil-to-Lymphocyte Ratio is Independently Associated With Inflammatory Activity and Fibrosis Grade in Nonalcoholic Fatty Liver Disease","volume":"31","author":"Khoury","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-118667","article-title":"Relationship Between Oxidative Stress, Inflammation and Dyslipidemia With Fatty Liver Index in Patients With Type 2 Diabetes Mellitus","volume":"126","author":"Klisic","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0002-5","article-title":"High-Sensitivity C-reactive Protein as a Serum Predictor of Nonalcoholic Fatty Liver Disease Based on the Akaike Information Criterion Scoring System in the General Japanese Population","volume":"44","author":"Kogiso","year":"2009","journal-title":"J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1379","article-title":"Serum Adipocyte Fatty Acid-Binding Protein Levels are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients","volume":"32","author":"Koh","year":"2009","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.cgh.2020.02.011","article-title":"Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients With Nonalcoholic Fatty Liver Disease","volume":"18","author":"Koo","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20173","article-title":"Accuracy of Prediction Scores and Novel Biomarkers for Predicting Nonalcoholic Fatty Liver Disease in Obese Children","volume":"21","author":"Koot","year":"2013","journal-title":"Obes (Silver Spring)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.1919","article-title":"Relationship Between Ultrasound Features of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk Factors in Patients With Newly Diagnosed Type 2 Diabetes","volume":"123","author":"Kosmalski","year":"2013","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2011.0213","article-title":"Inflammatory Markers in Relation to Nonalcoholic Fatty Liver Disease in Urban South Indians","volume":"14","author":"Kuppan","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0172666","DOI":"10.1371\/journal.pone.0172666","article-title":"High-Normal Levels of hs-CRP Predict the Development of non-Alcoholic Fatty Liver in Healthy Men","volume":"12","author":"Lee","year":"2017","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.11569\/wcjd.v23.i25.4094","article-title":"Risk Factors for Nonalcoholic Fatty Liver Disease in Uygur People in Urumqi","volume":"23","author":"Liang","year":"2015","journal-title":"World Chin J Digestol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)31279-4","article-title":"P1081: Hyperplastic Colonic Polyps Link to Nonalcoholic Steatohepatitis and Vitamin D Deficiency","volume":"62","author":"Mahamid","year":"2015","journal-title":"J Hepatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2020.08.005","article-title":"Screening for Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus Using Transient Elastography -\u00a0a Prospective, Cross Sectional Study","volume":"82","author":"Mikolasevic","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1526","article-title":"Should Nonalcoholic Fatty Liver Disease be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects","volume":"31","author":"Musso","year":"2008","journal-title":"Diabetes Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e49286","DOI":"10.1371\/journal.pone.0049286","article-title":"Non-Alcoholic Fatty Liver Disease is Closely Associated With Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India","volume":"8","author":"Nigam","year":"2013","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e65211","DOI":"10.1371\/journal.pone.0065211","article-title":"Soluble CD14 Levels Reflect Liver Inflammation in Patients With Nonalcoholic Steatohepatitis","volume":"8","author":"Ogawa","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03362.x","article-title":"Insulin Resistance and C-reactive Protein as Independent Risk Factors for non-Alcoholic Fatty Liver Disease in non-Obese Asian Men","volume":"19","author":"Park","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1068","article-title":"Association Between Cytokines and Liver Histology in Children With Nonalcoholic Fatty Liver Disease","volume":"1","author":"Perito","year":"2017","journal-title":"Hepatol Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"ofx153","DOI":"10.1093\/ofid\/ofx153","article-title":"The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus","volume":"4","author":"Price","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01823.x","article-title":"Non-Alcoholic Fatty Liver Disease and its Association With Obesity, Insulin Resistance and Increased Serum Levels of C-reactive Protein in Hispanics","volume":"29","author":"Riquelme","year":"2009","journal-title":"Liver Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2013.28.1.41","article-title":"Tumor Necrosis Factor-Alpha as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study","volume":"28","author":"Seo","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.07.029","article-title":"Serum Sex Hormone-Binding Globulin Levels are Independently Associated With Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes","volume":"94","author":"Shin","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B58","doi-asserted-by":"publisher","first-page":"28814","DOI":"10.1038\/srep28814","article-title":"Interleukin-34 as a Fibroblast-Derived Marker of Liver Fibrosis in Patients With non-Alcoholic Fatty Liver Disease","volume":"6","author":"Shoji","year":"2016","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a Biomarker for Coronary Atherosclerosis in Nonalcoholic Fatty Liver Disease: Results From the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int J Cardiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.07.024","article-title":"The Severity of Nonalcoholic Fatty Liver Disease is Associated With Increased Cardiovascular Risk in a Large Cohort of non-Obese Asian Subjects","volume":"203","author":"Sung","year":"2009","journal-title":"Atherosclerosis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.56.271","article-title":"Serum Cytokeratin 18 M30 Antigen Level and its Correlation With Nutritional Parameters in Middle-Aged Japanese Males With Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"56","author":"Tabuchi","year":"2010","journal-title":"J Nutr Sci Vitaminol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7401","article-title":"Parabolic Relationship Between Sex-Specific Serum High Sensitive C Reactive Protein and non-Alcoholic Fatty Liver Disease in Chinese Adults: A Large Population-Based Study","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.0075","article-title":"Increased Plasma CgA Levels Associated With Nonalcoholic Fatty Liver Disease","volume":"26","author":"Wu","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.5754\/hge13916","article-title":"High-Sensitivity C-reactive Protein is a Strong Predictor of non-Alcoholic Fatty Liver Disease","volume":"61","author":"Yeniova","year":"2014","journal-title":"Hepato-Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-007-2060-x","article-title":"High-Sensitivity C-reactive Protein is an Independent Clinical Feature of Nonalcoholic Steatohepatitis (NASH) and Also of the Severity of Fibrosis in NASH","volume":"42","author":"Yoneda","year":"2007","journal-title":"J Gastroenterol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e13271","DOI":"10.1097\/MD.0000000000013271","article-title":"The Associations Among Helicobacter Pylori Infection, White Blood Cell Count and Nonalcoholic Fatty Liver Disease in a Large Chinese Population","volume":"97","author":"Yu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.11569\/wcjd.v16.i34.3910","article-title":"Detection and Significance of Serum TNF-\u03b1, Tgf-\u03b21 and hs-CRP in Patients With non-Alcoholic Fatty Liver Disease","volume":"16","author":"Zhu","year":"2008","journal-title":"World Chin J Digestol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/biology9040075","article-title":"Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis","volume":"9","author":"El-Derany","year":"2020","journal-title":"Biology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_887_19","article-title":"Association of High-Sensitivity C-reactive Protein (hs-CRP) With non-Alcoholic Fatty Liver Disease (NAFLD) in Asian Indians: A Cross-Sectional Study","volume":"9","author":"Kumar","year":"2020","journal-title":"J Family Med Primary Care"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00536","article-title":"Association Between Leukocyte Mitochondrial Dna Copy Number and Non-alcoholic Fatty Liver Disease in a Chinese Population Is Mediated by 8-Oxo-2\u2019-Deoxyguanosine","volume":"7","author":"Ma","year":"2020","journal-title":"Front Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.734847","article-title":"Pnpla3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"8","author":"Dallio","year":"2021","journal-title":"Front Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12144","article-title":"Relationship Between Fatty Liver and High-Sensitivity C-reactive Protein","volume":"9","author":"Taniguchi","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30429","article-title":"Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01566","article-title":"Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues","volume":"9","author":"Mu","year":"2018","journal-title":"Front Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0178672","DOI":"10.1371\/journal.pone.0178672","article-title":"Relationships of Serum High-Sensitivity C-reactive Protein and Body Size With Insulin Resistance in a Japanese Cohort","volume":"12","author":"Uemura","year":"2017","journal-title":"PloS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00040","article-title":"Crp-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells","volume":"10","author":"Bian","year":"2019","journal-title":"Front Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/370558a0","article-title":"Regulation of Tumour Necrosis Factor-Alpha Processing by a Metalloproteinase Inhibitor","volume":"370","author":"McGeehan","year":"1994","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.jhepr.2020.100101","article-title":"Combined Alcoholic and non-Alcoholic Steatohepatitis","volume":"2","author":"Ntandja Wandji","year":"2020","journal-title":"JHEP Rep: Innovation Hepatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/jhep.2002.33995","article-title":"Reduced Glutathione Depletion Causes Necrosis and Sensitization to Tumor Necrosis Factor-Alpha-Induced Apoptosis in Cultured Mouse Hepatocytes","volume":"36","author":"Nagai","year":"2002","journal-title":"Hepatology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.563321","article-title":"Nrf2 -617 C\/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens","volume":"11","author":"Huang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuy031","article-title":"Prebiotic and Probiotic Treatment of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"76","author":"Loman","year":"2018","journal-title":"Nutr Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2014.08.006","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients of Cardiovascular Diseases and its Association With hs-CRP and TNF-\u03b1","volume":"66","author":"Ajmal","year":"2014","journal-title":"Indian Heart J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome Activation and Function in Liver Disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) - Pathogenesis, Classification, and Effect on Drug Metabolizing Enzymes and Transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1042\/CS20100387","article-title":"Enhanced Expression of Pro-Inflammatory Mediators and Liver X-receptor-regulated Lipogenic Genes in non-Alcoholic Fatty Liver Disease and Hepatitis C","volume":"120","author":"Lima-Cabello","year":"2011","journal-title":"Clin Sci (Lond Engl: 1979)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.591495","article-title":"\u03b2-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12219","article-title":"Distinct Cytokines Balance the Development of Regulatory T Cells and interleukin-10-producing Regulatory B Cells","volume":"141","author":"Holan","year":"2014","journal-title":"Immunology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6489012","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nature18629","article-title":"Inflammasome-Activated Gasdermin D Causes Pyroptosis by Forming Membrane Pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41419-018-1004-0","article-title":"Taurine Attenuates Arsenic-Induced Pyroptosis and Nonalcoholic Steatohepatitis by Inhibiting the Autophagic-Inflammasomal Pathway","volume":"9","author":"Qiu","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.880298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T02:18:17Z","timestamp":1651803497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.880298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2022.880298"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.880298","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"880298"}}